Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Jan;10(1):47-53.
doi: 10.1007/s11912-008-0008-9.

The clinical management of BRCA1 and BRCA2 mutation carriers

Anthony P Gulati  1 , Susan M Domchek
Affiliations
Review

The clinical management of BRCA1 and BRCA2 mutation carriers

Anthony P Gulati et al. Curr Oncol Rep. 2008 Jan.

Abstract

Mutations in the cancer susceptibility genes BRCA1 and BRCA2 are associated with significantly increased risks of breast and ovarian cancer. Fortunately, effective strategies are available to reduce these risks, including genetic testing, which is an important consideration in determining management of patients with a strong family history of cancer. This article reviews the current evidence for risk-reducing strategies in BRCA1 and BRCA2 mutation carriers and outlines future research directions. In particular, screening controversies and current guidelines are discussed, as are issues related to prophylactic mastectomy and oophorectomy.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. N Engl J Med. 2007 Jul 12;357(2):115-23 - PubMed
    1. Br J Cancer. 2004 Nov 29;91(11):1911-5 - PubMed
    1. Lancet Oncol. 2006 May;7(5):402-6 - PubMed
    1. J Med Genet. 2005 Jul;42(7):602-3 - PubMed
    1. JAMA. 2004 Apr 14;291(14):1701-12 - PubMed

Substances

LinkOut - more resources